Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort study (INTerACT study)

BACKGROUND & OBJECTIVES: The high mortality associated with the thrombotic events in hospitalized COVID-19 patients resulted in the usage of anticoagulants in varying doses. Whether high-dose anticoagulants have led to better outcomes or higher incidence of clinically significant bleeding events...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Ajay, Dhir, Ankita, Kajal, Kamal, Naik, Naveen B., Lazar, Michelle Shirin, Puri, G. D., Soni, Shiv Lal, Neupane, Adhip, Ganesh, Venkata, Kaloria, Narender, Saini, Kulbhushan, Hazarika, Amarjyoti, Mahajan, Varun, Singla, Karan, Bhalla, Ashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807207/
https://www.ncbi.nlm.nih.gov/pubmed/36124497
http://dx.doi.org/10.4103/ijmr.ijmr_2292_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807207/
https://www.ncbi.nlm.nih.gov/pubmed/36124497
http://dx.doi.org/10.4103/ijmr.ijmr_2292_21

Ejemplares similares